Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$310,542,805
-$43,148,211 QoQ
Shares Held
12,896,296
+2.4% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#50
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $4,791,103,609 across 11 Drug Manufacturers - General names. PFE ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,277,161 | $1,531,865,340 | |
| 2 | JNJ |
Johnson & Johnson
|
3,563,268 | $904,963,170 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
12,226,954 | $704,517,086 | |
| 4 | ABBV |
AbbVie Inc.
|
2,280,159 | $573,779,209 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,455,664 | $315,552,823 | |
| 6 | PFE |
Pfizer Inc
This page
|
12,896,296 | $310,542,805 | |
| 7 | AMGN |
Amgen Inc
|
613,694 | $222,230,868 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,705,761 | $215,505,842 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $310,542,805 | 12,896,296 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $353,691,016 | 12,595,834 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $307,552,000 | 12,351,486 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $315,359,282 | 12,376,738 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $304,949,524 | 12,580,426 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $262,677,352 | 10,366,115 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $264,591,911 | 9,973,310 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $254,081,274 | 8,779,588 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $200,518,303 | 7,166,487 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $171,098,810 | 6,165,723 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $162,665,971 | 5,650,086 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $164,243,242 | 4,951,560 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $229,606,488 | 6,259,719 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $284,188,357 | 6,965,401 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $508,738,796 | 9,928,548 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $461,803,260 | 10,553,091 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $621,845,122 | 11,860,483 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $611,196,563 | 11,805,999 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $622,189,710 | 10,536,659 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $385,781,202 | 8,969,570 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $359,053,063 | 9,168,873 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $329,441,126 | 9,093,048 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $256,031,878 | 6,955,498 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $316,069,589 | 8,612,259 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $152,021,178 | 4,648,961 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $207,931,105 | 6,370,447 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||